Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,General Medicine,Surgery
Reference146 articles.
1. Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee ShU (2017) Glioblastoma Multiforme: of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev 18(1):3–9
2. Robles P, Fiest KM, Frolkis AD (2015) The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis. Neuro-Oncology 17(6):776–783
3. Nizamutdinov D et al (2017) Survival Outcomes Prognostication in Glioblastoma Diagnosed Patients. World Neurosurg S1878–S8750
4. Iaccarino C, Orlandi E, Ruggeri F, Nicoli D, Torricelli F, Maggi M, Cerasti D, Pisanello A, Pedrazzi G, Froio E, Crafa P, D'Abbiero N, Michiara M, Ghadirpour R, Servadei F (2015) Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy. Clin Neurol Neurosurg 132:1–8
5. Villani V, Casini B, Pace A (2015) The prognostic value of pyrosequencing-detected MGMT promoter Hypermethylation in newly diagnosed patients with glioblastoma. Dis Markers 2015:1–6
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献